Spectranetics to Hold 2015 First Quarter Financial Results Conference Call on April 23
April 13 2015 - 4:01PM
The Spectranetics Corporation (Nasdaq:SPNC) today announced that
the Company will release 2015 first quarter financial results after
market close on Thursday, April 23, 2015. Company management will
host an investment-community conference call beginning at 2:30 p.m.
Mountain Time (4:30 p.m. Eastern Time) on Thursday, April 23 to
discuss those results and to answer questions.
Individuals interested in listening to the conference call may
do so by dialing (877) 561-2747 for domestic callers, or (973)
409-9689 for international callers, or from the webcast on the
investor relations section of the Company's website at:
www.spectranetics.com. The webcast will be available on the
Company's website for 14 days following the completion of the
call.
About Spectranetics
SPNC develops, manufactures, markets and distributes single-use
medical devices used in minimally invasive procedures within the
cardiovascular system. The Company's products are sold in over 65
countries and are used to treat arterial blockages in the heart and
legs and in the removal of pacemaker and defibrillator leads.
Spectranetics recently acquired AngioScore Inc., a leading
developer, manufacturer and marketer of cardiovascular, specialty
scoring balloons and the Stellarex drug-coated balloon platform
from Covidien.
The Company's Vascular Intervention (VI) products include a
range of laser catheters for ablation of blockages in arteries
above and below the knee as well as the AngioSculpt® scoring
balloon used in both peripheral and coronary procedures and the
Stellarex drug-coated balloon platform. The Company also markets
support catheters to facilitate crossing of peripheral and coronary
arterial blockages, and retrograde access and guidewire retrieval
devices used in the treatment of peripheral arterial blockages,
including chronic total occlusions. The Company markets aspiration
and cardiac laser catheters to treat blockages in the heart.
The Lead Management (LM) product line includes excimer laser
sheaths, dilator sheaths, mechanical sheaths and accessories for
the removal of pacemaker and defibrillator cardiac leads.
For more information, visit www.spectranetics.com.
CONTACT: COMPANY CONTACTS:
Spectranetics Corporation
Guy Childs, Chief Financial Officer
(719) 633-8333
INVESTOR CONTACTS:
Westwicke Partners, LLC
Lynn Pieper
(415) 202-5678
lynn.pieper@westwicke.com
The Spectranetics Corp. (MM) (NASDAQ:SPNC)
Historical Stock Chart
From Mar 2024 to Apr 2024
The Spectranetics Corp. (MM) (NASDAQ:SPNC)
Historical Stock Chart
From Apr 2023 to Apr 2024